Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (87)

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

  3. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  4. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis

  5. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

    Seminars in Thrombosis and Hemostasis

  6. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

    Thrombosis Research, Vol. 235, pp. 22-31

  7. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

  8. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

  9. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

  10. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  11. Pulmonary embolism: Put the sPESI into practice

    European Journal of Internal Medicine

  12. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  13. Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

    Thrombosis Research, Vol. 233, pp. 18-24

  14. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry

    Thrombosis Research, Vol. 236, pp. 88-96

  15. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology

  16. Time to Resolution of Right Ventricle Dysfunction in Patients With Acute Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 448-450

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial

    Thrombosis and haemostasis, Vol. 123, Núm. 7, pp. 723-733

  3. Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020

    JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772

  4. Changes in sleep-disordered breathing from the acute to the stable phase of pulmonary embolism: The ESAET study

    Sleep Medicine, Vol. 112, pp. 88-95